San DNAgo
San DNAgo Thanks to a fruitful partnership of academia and private enterprise, a vibrant biotech industry keeps on replicating itself.
San DNAgo Thanks to a fruitful partnership of academia and private enterprise, a vibrant biotech industry keeps on replicating itself.
Puncturing The ImClone Hype Could ImClone Systems’ Erbitux be a powerful cancer fighter after all? Maybe. A new study presented June 1 at a meeting of oncologists seems to boost that contention. But there are still reasons to doubt that Erbitux will be approved soon or that it will eventually be a blockbuster.